Latest Breaking News On - Patient reported outcomes through - Page 1 : comparemela.com

This interview segment with Dr. Mease featured a discussion about data presented at ACR 2023 on guselkumab and patients with psoriatic arthritis.

Spondyloarthritis psPhilipj measeUniversity of washington school medicineSwedish medical centerAmerican college of rheumatologyDrug administrationJanssen pharmaceuticals incCorevitas psoriatic arthritisSpondyloarthritis registryJanssen pharmaceuticalsWashington schoolPatient reported outcomes throughGuselkumab treatmentPatients with active psoriatic arthritisReal world data fromCorevitas psoriatic